1. Home
  2. Bills
  3. H.R. 5663

H.R. 5663 · 116th Congress · 2019–2020

Safeguarding Therapeutics Act

H.R. 5663 in the 116th Congress (2019–2020) became law — introduced on Jan 21, 2020, sponsored by Brett Guthrie with 2 co-sponsors.

During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Became law
Introduced
Jan 21, 2020
Co-sponsors
2
Policy area
Health
Public law
Public Law 116-304

What it does

Safeguarding Therapeutics Act This bill authorizes the Food and Drug Administration to destroy imported counterfeit medical devices.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Brett Guthrie (R-KY). Co-sponsors: 1 Democrat, 1 Republican.

Where it stands

  • IntroducedJan 21, 2020
  • Passed the HouseSep 21, 2020
  • Passed the SenateDec 8, 2020
  • Sent to the PresidentDec 24, 2020
  • Became lawJan 5, 2021

Latest action: Became Public Law No: 116-304. (Jan 5, 2021)

Other Health bills in the 116th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 5663 (116th Congress): Safeguarding Therapeutics Act,” https://www.capitolreceipts.com/bill/116-hr-5663/safeguarding-therapeutics-act (accessed 2026-10-14).

Open the interactive version ›